Chupp G, Nagase H, Skowasch D, Devouassoux G, et al. Switching to twice-yearly depemokimab from mepolizumab/benralizumab in severe asthma: A multicenter, randomized, double-blind, Phase 3A Clinical Trial (NIMBLE). Am J Respir Crit Care Med 2026 Feb 11:aamag031. doi: 10.1093.
PMID: 41738176